Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Apr;138(4):603-10.
doi: 10.1007/s00432-011-1135-5. Epub 2012 Jan 1.

Combination of a MDR1-targeted replicative adenovirus and chemotherapy for the therapy of pretreated ovarian cancer

Daniel T Rein  1 , Anne Volkmer, Gerd Bauerschmitz, Ines M Beyer, Wolfgang Janni, Markus C Fleisch, Anne Kathrin Welter, Dirk Bauerschlag, Thomas Schöndorf, Martina Breidenbach
Affiliations

Combination of a MDR1-targeted replicative adenovirus and chemotherapy for the therapy of pretreated ovarian cancer

Daniel T Rein et al. J Cancer Res Clin Oncol. 2012 Apr.

Abstract

Purpose: Targeted oncolytic adenoviruses capable of replication selectively in cancer cells are an appealing approach for the treatment of various cancer types refractory to conventional therapies. The aim of this study was to evaluate the effect of Ad5/3MDR1E1, a multidrug resistance gene 1 (MDR1)-targeted fiber-modified replication-competent adenovirus for the therapy of platinum-pretreated ovarian cancer in combination with cytostatic agents.

Methods: MDR1-specific tumor cell killing of Ad5/3MDR1E1 was systematically evaluated in chemotherapy naïve and pretreated ovarian cancer cells in vitro. Combinations of Ad5/3MDR1E1 and cytostatic agents were studied in vivo and in vitro. An in vivo hepatotoxicity model was used to evaluate liver toxicity.

Results: We demonstrate efficient oncolysis of Ad5/3MDR1E1 in chemotherapy-resistant ovarian cancer cells as well as therapeutic efficacy in an orthotopic mouse model. Further, combining Ad5/3MDR1E1 with paclitaxel resulted in greater therapeutic benefit than either agent alone.

Conclusion: These preclinical data suggest that a fiber-modified adenovirus vector under the control of the MDR1 promoter represents a promising treatment strategy for platinum-pretreated ovarian cancer as a single agent or in combination with conventional anticancer drugs.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Expert Opin Biol Ther. 2007 Sep;7(9):1347-61 - PubMed
    1. Cancer. 1956 Nov-Dec;9(6):1211-8 - PubMed
    1. Gene Ther. 2006 Nov;13(21):1534-44 - PubMed
    1. Cancer Res. 2006 Jul 15;66(14):7195-202 - PubMed
    1. Mol Ther. 2002 Jun;5(6):695-704 - PubMed

MeSH terms

Substances

LinkOut - more resources